Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Search for new drugs for treatment of tuberculosis.

Literature DB >> 11408205

Search for new drugs for treatment of tuberculosis.

I Orme¹.

Abstract

Entities: Disease

Mesh：

Substances：
Antitubercular Agents

Year: 2001 PMID： 11408205 PMCID： PMC90582 DOI： 10.1128/AAC.45.7.1943-1946.2001

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

19 in total

1. Disintegrating health services and resurgent tuberculosis in post-Soviet Tajikistan: an example of structural violence.

Authors: S Keshavjee; M C Becerra
Journal: JAMA Date: 2000-03-01 Impact factor: 56.272

2. Determination of the minimal effective dosages of ofloxacin and sparfloxacin against M. leprae in the mouse foot pad system.

Authors: I Traore; B Ji; C Lienhardt; P Bobin; J Grosset
Journal: Int J Lepr Other Mycobact Dis Date: 1996-06

3. Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis.

Authors: B P Kelly; S K Furney; M T Jessen; I M Orme
Journal: Antimicrob Agents Chemother Date: 1996-12 Impact factor: 5.191

4. Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection.

Authors: C M Shoen; M S DeStefano; M H Cynamon
Journal: Clin Infect Dis Date: 2000-06 Impact factor: 9.079

5. Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.

Authors: A M Lenaerts; S E Chase; M H Cynamon
Journal: Antimicrob Agents Chemother Date: 2000-11 Impact factor: 5.191

6. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

Authors: C Dye; S Scheele; P Dolin; V Pathania; M C Raviglione
Journal: JAMA Date: 1999-08-18 Impact factor: 56.272

7. A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions.

Authors: P S Skinner; S K Furney; M R Jacobs; G Klopman; J J Ellner; I M Orme
Journal: Antimicrob Agents Chemother Date: 1994-11 Impact factor: 5.191

8. In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis.

Authors: B JI; N Lounis; C Truffot-Pernot; J Grosset
Journal: Antimicrob Agents Chemother Date: 1995-06 Impact factor: 5.191

9. Comparison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculosis.

Authors: P S Skinner; S K Furney; D A Kleinert; I M Orme
Journal: Antimicrob Agents Chemother Date: 1995-03 Impact factor: 5.191

10. Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors: A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal: J Exp Med Date: 1993-12-01 Impact factor: 14.307

36 in total

1. Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compounds.

Authors: Vandana Singh; Rajesh Kumar Biswas; Bhupendra N Singh
Journal: Antimicrob Agents Chemother Date: 2013-12-16 Impact factor: 5.191

2. Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents.

Authors: Rajendra P Tangallapally; Raghunandan Yendapally; Robin E Lee; Anne J M Lenaerts; Richard E Lee
Journal: J Med Chem Date: 2005-12-29 Impact factor: 7.446

3. Anti-tuberculosis constituents from the stem bark of Micromelum hirsutum.

Authors: Cuiying Ma; Ryan J Case; Yuehong Wang; Hong-Jie Zhang; Ghee Teng Tan; Nguyen Van Hung; Nguyen Manh Cuong; Scott G Franzblau; Djaja Djendoel Soejarto; Harry H Fong; Guido F Pauli
Journal: Planta Med Date: 2005-03 Impact factor: 3.352

4. Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis.

Authors: Veronica Gruppo; Christine M Johnson; Karen S Marietta; Hataichanok Scherman; Erin E Zink; Dean C Crick; Linda B Adams; Ian M Orme; Anne J Lenaerts
Journal: Antimicrob Agents Chemother Date: 2006-04 Impact factor: 5.191

5. Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis.

Authors: Boris V Nikonenko; Rowena Samala; Leo Einck; Carol A Nacy
Journal: Antimicrob Agents Chemother Date: 2004-12 Impact factor: 5.191

6. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models.

Authors: Anne J Lenaerts; Veronica Gruppo; Karen S Marietta; Christine M Johnson; Diane K Driscoll; Nicholas M Tompkins; Jerry D Rose; Robert C Reynolds; Ian M Orme
Journal: Antimicrob Agents Chemother Date: 2005-06 Impact factor: 5.191